SHANTHI THANGAM: Open Payments
NPI 1417967423 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 22 payments from 7 companies in 2025. Trend: 2023 $790 · 2024 $767 · 2025 $584
Food & beverage: $472Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $172 |
| Alkermes, Inc. | 5 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $114 |
| Lundbeck LLC | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Corium, LLC | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: REXULTI, ARISTADA, CAPLYTA, UZEDY, Azstarys, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
